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ABSTRACT
ObjeCtive
To determine the effectiveness of a physical activity 
intervention for smoking cessation during pregnancy.
Design
Parallel group, randomised controlled, multicentre 
trial.
setting
13 hospitals in England, April 2009 to January 2014.
PartiCiPants
789 pregnant smokers, aged 16-50 years and at 10-24 
weeks’ gestation, who smoked at least one cigarette 
daily and were prepared to quit smoking one week 
after enrollment were randomised (1:1); 785 were 
included in the intention to treat analyses, with 392 
assigned to the physical activity group.
interventiOns
Interventions began one week before a target quit 
date. Participants were randomised to six weekly 
sessions of behavioural support for smoking cessation 
(control) or to this support plus 14 sessions combining 
supervised treadmill exercise and physical activity 
consultations.
Main OutCOMe Measures
The primary outcome was continuous smoking 
abstinence from the target quit date until end of 
pregnancy, validated by exhaled carbon monoxide or 
salivary cotinine levels. To assess adherence, levels of 
moderate-vigorous intensity physical activity were self 
reported and in a 11.5% (n=90) random subsample of 
participants, physical activity was objectively 
measured by an accelerometer.
results
No significant difference was found in rates of smoking 
abstinence at end of pregnancy between the physical 
activity and control groups (8% v 6%; odds ratio 1.21, 
95% confidence interval 0.70 to 2.10). For the physical 
activity group compared with the control group, there 
was a 40% (95% confidence interval 13% to 73%), 34% 
(6% to 69%), and 46% (12% to 91%) greater increase 
in self reported minutes carrying out physical activity 
per week from baseline to one week, four weeks, and 
six weeks post-quit day, respectively. According to the 
accelerometer data there was no significant difference 
in physical activity levels between the groups. 
Participants attended a median of four treatment 
sessions in the intervention group and three in the 
control group. Adverse events and birth outcomes 
were similar between the two groups, except for 
significantly more caesarean births in the control 
group than in the physical activity group (29% v 21%, 
P=0.023).
COnClusiOn
Adding a physical activity intervention to behavioural 
smoking cessation support for pregnant women did 
not increase cessation rates at end of pregnancy. 
During pregnancy, physical activity is not 
recommended for smoking cessation but remains 
indicated for general health benefits.
trial registratiOn
 Current Controlled Trials ISRCTN48600346.
Introduction
Maternal smoking in pregnancy is the main preventable 
cause of morbidity and death among women and 
infants. Smoking is associated with adverse pregnancy 
and birth outcomes, including miscarriage, still birth, 
prematurity, low birth weight, congenital abnormali-
ties, and neonatal or sudden infant death.1-3  In most 
high income countries at least 10% of women smoke 
during pregnancy,4-6  and the prevalence in low and 
middle income countries is rising.7  Smoking cessation 
during pregnancy improves birth outcomes,8  and 
behavioural support helps pregnant women to stop 
smoking.8  Use of nicotine replacement therapy during 
pregnancy seems to have little or no effect, and other 
pharmaceutical aids are contraindicated.9  The majority 
of pregnant women who receive behavioural support 
for smoking cessation do not stop8; thus new interven-
tions that add to the effectiveness of behavioural sup-
port are needed.
Physical activity programmes may add to the effec-
tiveness of behavioural support. In non-pregnant smok-
ers there is convincing evidence that physical activity 
reduces the intensity of urges to smoke, which are the 
main cause of relapse to smoking.10  Again in non- 
pregnant smokers, the trial evidence that physical activity 
aids cessation is mixed, with only one trial—of vigorous 
intensity physical activity—showing a long term benefit,11 
although most trials were small and had other design 
WhAT IS AlReAdy knoWn on ThIS TopIC
The evidence for physical activity programmes aiding smoking cessation is mixed
Pregnancy provides a compelling rationale for their use as drugs are 
contraindicated or ineffective and exercise has been shown to reduce cigarette 
cravings among pregnant smokers
Until now a randomised controlled trial of physical activity for smoking cessation 
in pregnancy has been lacking
WhAT ThIS STudy AddS
Our study suggests that a physical activity intervention has no benefit for helping 
women to quit smoking during pregnancy
However, physical activity remains indicated for general health benefits in 
pregnancy
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features that made the evidence difficult to interpret.12 
Adequately powered trials are needed with moderate 
intensity exercise (for example, brisk walking), which 
is likely to be more acceptable than vigorous exercise 
for most people.13  Moderate intensity physical activ-
ity is recommended for pregnancy, and pregnant 
smokers are likely to be receptive to such an interven-
tion.14 We conducted a parallel group, randomised 
controlled trial to assess the effectiveness of a physi-
cal activity intervention for smoking cessation during 
pregnancy.
Methods
study population
Between April 2009 and November 2012, we recruited 
pregnant women by telephone after their first antenatal 
booking visit (conducted at either hospital or a commu-
nity clinic), from 13 hospital antenatal clinics in London, 
Surrey, Kent, and Cheshire. In the United Kingdom all 
pregnant women are booked for delivery in the second-
ary care setting, although a small fraction of women 
deliver at home or in primary care (midwife led) units. 
Pregnant smokers are, by definition, high risk and 
would be expected to be cared for in hospital. Inclusion 
criteria were wanting to stop smoking, wanting help 
with stopping smoking, agreeing to set a date for quit-
ting smoking within one week of the baseline visit, age 
16-50 years, being at 10-24 weeks of gestation, cigarette 
consumption of five or more daily before pregnancy, 
currently smoking one or more cigarettes daily, and 
being able to walk continuously for 15 minutes. Exclu-
sion criteria were medical conditions potentially exac-
erbated by exercise or advised against exercise by a 
doctor, inability to provide informed consent or com-
plete questionnaires in English, drug or alcohol depen-
dence, and currently using or wanting to use nicotine 
replacement therapy. We recruited women irrespective 
of their current level of physical activity or motivation 
towards increasing their activity.
study protocol and interventions
Wandsworth research ethics committee approved the 
published protocol15 (available at www.trialsjournal.
com/content/13/1/186). All participants provided writ-
ten informed consent. We offered all participants six 
weekly sessions of 20 minutes of individual behavioural 
cessation support, starting one week before the quit 
date and ending four weeks afterwards. This interven-
tion aimed to support smoking cessation by reinforcing 
commitment to abstinence and solving women’s prob-
lems about maintaining abstinence. It incorporated all 
43 behaviour change techniques defined in a published 
taxonomy16  and as described in the protocol,15 except 
for the provision of rewards contingent on successfully 
stopping smoking. The emphasis was on the impor-
tance of avoiding lapses, managing withdrawal symp-
toms and urges to smoke, enhancing self confidence, 
and prevention of relapse.
At enrollment we randomised participants to 
behavioural cessation support alone or to behavioural 
cessation support plus a physical activity intervention, 
combining supervised exercise with physical activity 
consultations. Fourteen sessions of supervised exercise 
were offered over eight weeks; twice a week for six 
weeks then weekly for two weeks. At each session the 
participants walked at a moderate intensity on a tread-
mill for up to 30 minutes. Immediately before each 
treadmill session, the women received behavioural sup-
port. At the first two treadmill sessions, and then on 
every other occasion (total of nine consultations), this 
support aimed to identify opportunities to incorporate 
physical activity into women’s lives, to motivate them to 
use physical activity to reduce the urge to smoke, and to 
help them use behavioural strategies to improve adher-
ence to these plans. These 20 minute consultations 
incorporated 19 behaviour change techniques, as 
described in the study protocol.15 The women were 
advised to be active for at least 10 minutes at a time, 
progressing towards 30 minutes of activity on at least 
five days a week. The emphasis was on brisk walking, 
and pedometers (Digi-Walker SW-200; Yamax, Notting-
ham, UK) were supplied, with researchers setting indi-
vidualised step count targets. We also provided a DVD 
on antenatal exercise. On the other occasion the women 
received behavioural support for smoking sessions (up 
to six sessions) as for the control group. For each ses-
sion attended, participants were paid £7 towards travel.
randomisation
An independent statistician generated a randomisation 
list using Stata, with random permuted blocks of ran-
dom size stratified by recruitment centre, in a 1:1 ratio. 
At enrollment the sequence was concealed from 
researchers who confirmed consent and eligibility on 
an online database before allocation was revealed. It 
was not feasible to mask participants or researchers to 
group allocation.
Data collection
We collected personal and smoking characteristics of 
the women at baseline, including score on the Fager-
ström test for cigarette dependence,17  self reports of 
moderate-vigorous intensity physical activity in the pre-
vious week (bouts of ≥10 minutes) using the seven day 
physical activity recall interview,18  Edinburgh postnatal 
depression scale score,19  confidence about taking up 
physical activity20  and stopping smoking,21  alcohol 
consumption,22  weekly cigarette withdrawal symp-
toms,23  and weekly smoking urges (combining ratings 
of strength and frequency).24 At the first antenatal book-
ing visit the midwife measured the women’s clothed 
weight (without shoes) on a digital scale. During all 
contacts, the women were asked about adverse events. 
Research midwives examined the women’s medical 
records monthly for adverse events. The records were 
also checked by the research midwives for maternal and 
infant outcome data after delivery.
Outcomes
The primary outcome was self reported continuous 
abstinence from smoking between quit date and end of 
pregnancy. We permitted temporary, brief smoking 
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lapses of up to five cigarettes in total (on up to five occa-
sions).25 Abstinence was validated by the concentra-
tion of either exhaled carbon monoxide (<8 ppm) or 
salivary cotinine (<10 ng/mL); if both measures were 
available both were required for validation. We 
assessed the levels of carbon monoxide weekly up to 
four weeks after the quit day and at the end of preg-
nancy. Cotinine was measured at four weeks post-quit 
date and end of pregnancy.
Secondary outcomes included validated abstinence 
at four weeks after the quit date and self reported absti-
nence by telephone at the final follow-up at six months 
after birth (completed in January 2014). At one week 
after the quit date we further assessed weekly urges to 
smoke, weekly withdrawal symptoms, and confidence 
about taking up physical activity and stopping smok-
ing. We also further assessed the Edinburgh postnatal 
depression scale scores at the end of pregnancy and six 
months after birth. A researcher weighed the women at 
the end of pregnancy using the same method as used by 
the midwife at the first antenatal booking visit.
To assess adherence we assessed self reported physi-
cal activity at weeks 1, 4, and 6 after the quit date and at 
the end of pregnancy. In an 11.5% random subsample of 
participants (the target was 10%) physical activity was 
objectively measured using an accelerometer (Model 
GT1M or GT3X; Actigraph, Pensacola, FL). Only 90 
women were asked to wear an accelerometer as our 
pilot work showed that most women would not tolerate 
devices worn around the waist, and at the start of the 
study validated wrist worn accelerometers were not 
commercially available; therefore, as the only practica-
ble alternative, we used self reported physical activity 
for the primary analysis of physical activity. The accel-
erometer was worn over the right hip, in the fourth 
week after the quit date and for up to seven consecutive 
days, recording “dry land” activity during waking hours 
at one minute epochs. Use of National Health Service 
behavioural support for smoking cessation, beyond 
that offered in the study, and nicotine replacement ther-
apy were self reported. Participants received a £10 
shopping voucher for completing end of pregnancy and 
six month postnatal follow-ups (that is, £20 maximum).
statistical analysis
We anticipated a cessation rate of 15% in the control 
group, on the basis that 9% of pregnant women who are 
smokers stop smoking with usual care after their first 
antenatal visit, and that with behavioural support 
another 6-7% quit.26  Based on pilot work,14  we pro-
jected a cessation rate of 23% in the treatment group. 
We calculated that 866 participants would provide 83% 
power at a 5% significance level to detect an absolute 
difference of 8 percentage points in the occurrence of 
the primary outcome between the two groups (that is, 
15% in the control group versus 23% in the physical 
activity group), corresponding to an odds ratio of 1.69 or 
a relative risk of 1.53. The prime aim of assisting smok-
ing cessation in pregnancy is to improve the outcome of 
the pregnancy. The latest version of the Cochrane 
review of psychosocial interventions for supporting 
women to stop smoking in pregnancy shows evidence 
that such interventions were effective in helping women 
stop smoking and improving perinatal outcomes.27 For 
example, the main subgroup in the review comprising 
counselling versus usual care showed a relative risk of 
1.44 for achieving abstinence in late pregnancy, the 
same outcome we used. No individual trial of smoking 
cessation in pregnancy detected differences in perinatal 
outcomes by intervention status, but evidence of this 
has been shown by the meta-analysis of all trials in the 
review. When pooled together, these interventions pro-
duced the following relative risks for intervention ver-
sus control: low birth weight 0.82 (95% confidence 
interval 0.71 to 0.94), preterm birth 0.82 (0.70 to 0.96), 
and increased mean birth weight 41 g (18 to 63 g). Thus, 
relative increases in the rate of cessation of a similar 
size to the one we were aiming to detect have led to 
meaningful improvements in perinatal outcomes and 
would be expected to do so in this trial.
Analysis was on an intention to treat basis; we 
assumed participants with missing outcome data to be 
smoking.25 Using logistic regression we compared the 
proportion of women reporting continuous smoking 
abstinence at the end of pregnancy between study 
groups, with adjustment for recruitment centre. We 
assessed statistical significance with the likelihood 
ratio test, with the estimate of effect given as the odds 
ratio and 95% confidence interval. A secondary analysis 
adjusted for recruitment centre and the potentially 
important prognostic baseline factors of cigarette 
dependence, age, depression, maternal educational 
level, and partner’s smoking status. In addition, we 
tested for an interaction between baseline physical 
activity (<150 mins/week moderate-vigorous physical 
activity versus ≥150 mins/week moderate-vigorous 
physical activity) and the rates of smoking abstinence 
at the end of pregnancy. We also assessed whether 
changes in physical activity levels affected smoking ces-
sation rates: exclusively in the physical activity group 
we assessed, among those reporting <150 mins/week 
moderate-vigorous physical activity at baseline, 
whether reporting ≥150 mins/week moderate-vigorous 
physical activity at four weeks or six weeks after the 
quit day was associated with smoking abstinence at 
those times.
For the primary outcome, to assess the influence of 
the assumption that missing data equals “smoking” on 
the effect size, we tested various scenarios of the associ-
ation between smoking and having missing data using 
the Hedeker method.28 For ratings of withdrawal symp-
toms, urge to smoke, confidence for quitting smoking, 
and confidence for taking physical activity we calcu-
lated a change score between baseline and one week 
post-quit, and we used t tests to compare scores for the 
two groups. We compared the use of nicotine replace-
ment therapy and behavioural support between the two 
groups using χ2 tests.
We log transformed (log base 10) self reported 
weekly minutes of moderate-vigorous physical activity 
(in bouts of ≥10 minutes) to normality, and we anal-
ysed the difference in self reported physical activity 
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between the groups over time using a mixed effects 
linear regression model to account for within person 
correlations over time. In this model, we estimated the 
difference between treatment groups at each time 
point with adjustment for visit time, baseline minutes 
of moderate-vigorous physical activity, the interaction 
of visit time and baseline minutes of moderate-vigor-
ous physical activity, and recruitment centre. We ana-
lysed the accelerometer data using KineSoft software 
(version 3.3.76; Loughborough, UK). Files with at least 
10 hours of valid wear time on one or more days were 
retained in the analyses. We used standard cut-off 
points to determine moderate-vigorous physical 
 activity.29 The two study groups were compared 
(Mann-Whitney tests) for accelerometer reports of 
moderate-vigorous physical activity, both when 
restricting the analysis to bouts of at least 10 minutes 
(to allow comparison with the self report data) and 
when including all moderate-vigorous physical activ-
ity, irrespective of duration. For the week when the 
accelerometer was worn we used Wilcoxon tests to 
compare self reports of moderate-vigorous physical 
activity with accelerometer data.
We compared the changes in depression scores for 
the two groups using a mixed effect linear regression, 
adjusted for visit time, baseline Edinburgh postnatal 
depression scale score, the interaction of visit time and 
baseline Edinburgh postnatal depression scale score, 
and recruitment centre. This model allows for correla-
tion between the repeated measurements at the end of 
pregnancy and six months. Maternal weight at end of 
pregnancy was compared for the two groups using lin-
ear regression, with adjustment for early pregnancy 
weight and recruitment centre. As some of the “end of 
pregnancy” weights were recorded before the birth and 
some after, we conducted separate regressions for 
before (gestational weight change) and after (postnatal 
weight retention) birth.
Using logistic regression or linear regression adjusted 
for recruitment centre we compared fetal and maternal 
birth outcomes between the two groups. For fetal out-
comes, the primary analysis was of singleton births. We 
also conducted a sensitivity analysis, including multi-
ple births, with clustering of outcomes accounted for by 
using an approach that regards each woman as the 
“cluster” and her number of offspring as the cluster 
size.30 A χ2 test was used to compare adverse events for 
the groups.
Results
Figure 1  shows the numbers of participants who were 
enrolled and excluded. Four women were excluded 
post-randomisation; two women (physical activity 
group) were enrolled twice in sequential pregnancies 
(their second enrolment was removed) and two women 
(control group) were ineligible at their baseline visit 
and had been randomised erroneously. When ineligible 
patients are mistakenly randomised into a trial it is 
acceptable to exclude participants’ data within an 
intention to treat approach without risking bias.31  Of 
785 pregnancies, 774 were singleton, 10 were twins, and 
one was unknown as the participant withdrew consent. 
The baseline characteristics of participants in the two 
groups were similar (table 1 ). Over half (54%) were 
smoking at least 10 cigarettes a day. By self report, 70% 
were achieving the recommendation of 150 minutes a 
week of moderate-vigorous physical activity (in bouts of 
≥10 minutes).13
The follow-up rate for the primary outcome was 
88.8% (697 participants), and this was similar for the 
two study groups. Of the 88 participants (11.2%) who did 
not complete the assessments necessary for the analysis 
of the primary outcome, 43 (48.9%) were known to have 
smoked from the follow-up assessments that they did 
complete. Evidence was lacking of a significant differ-
ence in this rate between study groups. Only for the 
remaining 45 participants (5.7% of all participants) was 
it necessary to assume continued smoking or relapse.
Participants attended a median of four treatment ses-
sions in the intervention group and three in the control 
group (table 2 ). Physical activity increased after base-
line, but the increase was significantly greater in the 
physical activity group, by 33% (95% confidence inter-
val 14% to 56%), 28% (7% to 52%), and 36% (12% to 
65%) at one week, four weeks, and six weeks post-quit 
day, respectively (fig 2, table 2). Only 28 women reported 
receiving NHS face to face support for smoking cessa-
tion, besides that offered in the trial, and 60 women 
reported using nicotine replacement therapy; the num-
bers reporting this support were similar between the 
two groups.
Of 90 participants (11.5% of total sample) asked to wear 
an accelerometer during the fourth week after the quit 
date, 78 (87%) provided valid data (37 in physical activity 
group), 10 provided insufficient data, and two wore 
devices with technical problems. Participants providing 
accelerometer data had similar baseline characteristics 
Assigned to behavioural support only (n=395)
Received behavioural support only (n=395)
Assigned to behavioural support plus physical
  activity intervention (n=394)
Received behavioural support plus physical
  activity intervention (n=393)
Women recorded as smokers at rst antenatal visit (n=8096)
Randomisation (n=789)
Lost to follow-up (n=53):
  Fetal or infant deaths (n=15)
  Unable to contact or refused to attend (n=38)
Lost to follow-up (n=35):
  Fetal or infant deaths (n=9)
  Withdrew consent before providing baseline
    data (n=1)
  Unable to contact or refused to attend (n=25)
Included in primary analysis (n=393)
Excluded from analysis as did not meet
  inclusion criteria at baseline visit (n=2)
Included in primary analysis (n=392)
Excluded from analysis owing to being enrolled
  twice (n=2)
Excluded (n=7307):
  Unable to contact (n=2169)
  Declined to participate (n=2324)
  Did not meet inclusion criteria (n=2583)
  Other reasons (n=231)
Fig 1 | Flow of participants through trial. Participants lost to follow-up included women 
who experienced fetal or infant loss and were not assessed for smoking status
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to  the total sample. Seventy two per cent had valid 
 accelerometer data for at least four days. The median 
duration of moderate-vigorous physical activity per day 
by  accelerometer, when only including bouts of at least 
10 minutes, was similar between the physical activity 
(7.5 minutes, interquartile range 0-15.5) and control 
groups (8.0 minutes, 0-16.2), P=0.816). When including 
all moderate-vigorous physical activity, irrespective of 
duration, activity levels per day tended to be higher for 
the physical activity group (median 38.0 minutes, inter-
quartile range 20.0-52.6) versus control group (31.2, 19.0-
44.1), although this difference did not reach significance 
(P=0.538). During the week when the accelerometer 
was worn, moderate-vigorous physical activity per day 
(in bouts of ≥10 minutes) was significantly higher by self 
report than by accelerometer; this being the case for the 
control group (median difference 23.2 (interquartile 
range 6.1-37.1) minutes, P<0.001), and even more so for 
the physical activity group (29.7, 17.1-49.4) minutes, 
P<0.001).
There was no significant difference in smoking 
abstinence rates between the two groups at follow-up 
(table 3). The rate of validated continuous abstinence 
at end of pregnancy was 8% in the physical activity 
group and 6% in the control group (odds ratio for phys-
ical activity group, adjusted for recruitment centre only 
1.21, 95% confidence interval 0.70 to 2.10). At four 
weeks the validated abstinence rate was 13% in the 
physical activity group and 16% in the control group 
(odds ratio adjusted for recruitment centre only 0.79, 
0.53 to 1.18). At six months after birth, the rate of self 
reported abstinence was 6% in the physical activity 
group and 4% in the control group (odds ratio adjusted 
for recruitment centre only 1.55, 95% confidence inter-
val 0.81 to 2.97). Fully adjusted analyses yielded similar 
findings (table 3). The sensitivity analyses showed that 
the observed effect size and its statistical significance 
were independent of the influence of missing data for 
the primary outcome. There was no significant interac-
tion between baseline self reports of moderate-vigor-
ous physical activity (<150 v ≥150 mins/week physical 
activity) and the effect of the intervention on smoking 
abstinence at the end of pregnancy (adjusted for 
recruitment centre only: odds ratio 3.03, 95% confi-
dence interval 0.68 to 13.40, P=0.129). Nor was there 
any evidence that changes in self reports of physical 
activity in the physical activity group were significantly 
associated with smoking abstinence (adjusted for 
recruitment centre only: odds ratio at four weeks 2.21, 
95% confidence interval 0.48 to 10.12, P=0.321, and at 
six weeks 2.36, 0.41 to 13.51, P=0.362).
At the end of pregnancy, the Edinburgh postnatal 
depression scale score was significantly higher 
(P=0.017) for the physical activity group compared with 
the control group (table 4 ). There was no significant dif-
ference in scores between the groups at six months. 
There was no significant difference in gestational or 
postnatal weight between the groups (table 5). The 
baseline characteristics among those providing data on 
depression and weight were similar to those for the total 
trial sample and were comparable between the study 
groups.
Between baseline and one week post-quit, ratings for 
confidence for participating in physical activity for the 
physical activity compared with control group increased 
significantly (P=0.004), but there was no significant 
change in ratings for individual withdrawal symptoms, 
urge to smoke, or confidence for quitting smoking. The 
total number of women or their infants who had at least 
one adverse event or serious adverse event was 217 
(55%) in the physical activity group and 219 (56%) in the 
control group (odds ratio 0.99, 95% confidence interval 
0.75 to 1.32) (see supplementary table on bmj.com). 
There were no significant differences between the 
groups for any adverse event or serious adverse event, 
table 1 | baseline characteristics, according to study group. values are numbers 
(percentages) unless stated otherwise
Characteristics
Physical activity 
group (n=391)
Control group 
(n=393)
Mean (SD) age (years) 27.2 (6.1) 27.8 (6.5)
Mean (SD) age at leaving full time education (years)* 17.8 (3.0) 18.0 (3.3)
Mean (SD) weight (kg)† 69.2 (14.1) 70.9 (15.9)
Mean (SD) body mass index (kg/m2)† 25.6 (5.0) 26.6 (5.6)
Mean (SD) gestational age (weeks) 15.6 (3.3) 15.6 (3.3)
Mean (SD) Edinburgh postnatal depression scale score 7.6 (5.3) 7.7 (5.0)
Median (interquartile range) No of cigarettes smoked 
daily before pregnancy
20 (12-20) 20 (12-20)
Median (interquartile range) No of cigarettes smoked 
daily at randomisation
10 (5-12) 10 (5-15)
Median (interquartile range) Fagerström test of 
cigarette dependence score‡
4 (2-5) 4 (2-5)
Median (interquartile range) expired carbon monoxide 
level (ppm)§
10 (7-14) 10 (6-14)
Median (interquartile range) self report of weekly 
moderate-vigorous physical activity (mins)
210 (125-350) 225 (130-360)
Married or living with partner 230 (59) 221 (56)
Partner smokes¶ 261 (67) 250 (64)
White** 308 (79) 298 (76)
Professional or managerial occupation 46 (12) 53 (13)
Smoked in a previous pregnancy†† 186 (78) 193 (78)
Edinburgh postnatal depression scale score ≥13 68 (17) 75(19)
Self report of ≥150 mins/week of moderate-vigorous 
physical activity
275 (70) 273 (69)
Self report of walking as main type of physical activity 301 (77) 313 (80)
Parity§§:
 0-1 317 (81) 309 (79)
 2-3 67 (17) 75 (19)
 >4 7 (2) 9 (2)
Previous preterm birth‡‡ 68 (17) 61 (16)
Very or extremely high confidence for quitting smoking 89 (23) 98 (25)
Very or extremely confident of doing 30 mins of physical 
activity on at least 5 days a week during pregnancy
274 (70) 277 (71)
Takes alcohol more than twice a week 6 (2) 5 (1)
Consumes >3 alcoholic drinks on a drinking day¶¶*** 14 (16) 3 (4)
Baseline data were not recorded for one participant in physical activity group who withdrew consent shortly after 
randomisation.
*Data exclude 41 women who were still in full time education.
†Not recorded for one participant in control group.
‡Not recorded for one participant in physical activity group.
§Not recorded for one participants in physical activity group and two in control group.
¶Excludes 92 women with no partner.
**Race or ethnic group was self reported and categorised according to standard UK census categories.
††Excludes 297 with no previous pregnancies.
‡‡Any previous pregnancy of duration 24-37 weeks. 
§§Number of previous pregnancies progressing beyond 24 weeks.
¶¶Excludes 617 women responding “not applicable” (that is, not consuming alcohol).
***Significant difference between groups (P=0.011), using Fisher’s exact test. This variable was not related to the 
primary outcome and therefore was not adjusted for in the analysis. There were no other significant differences 
between the groups.
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including maternal or fetal adverse events as probable 
complications of pregnancy or neonatal adverse events. 
Birth outcomes were similar between the two groups, 
including miscarriages, stillbirths, neonatal deaths, 
birth weights, and preterm births, except there were sig-
nificantly fewer deliveries by caesarean section in the 
physical activity group than in the control group (29% v 
21%, P=0.023, table 6). When including twin births the 
findings for birth outcomes were similar.
discussion
Supplementing behavioural support with a physical 
activity intervention was no more effective in aiding 
smoking cessation during pregnancy than behavioural 
support alone. These findings were observed despite 
women in the physical activity group reporting 33% to 
36% greater increases in physical activity than women 
in the control group during the intervention period.
strengths and limitations of this study
In this study the limitations of previous trials of physi-
cal activity interventions for smoking cessation12  were 
overcome by implementing a multicentre trial, offering 
an intensive physical activity intervention with support 
to increase physical activity as an aid for smoking ces-
sation in addition to supervised exercise sessions, 
assessing and validating physical activity in both 
groups, using a robust outcome of continuous absti-
nence, and offering a pragmatic intervention that could 
be readily integrated into routine healthcare in the 
NHS. At baseline the participants’ average gestational 
age, age, and cigarette consumption were similar to that 
of participants in another recent large pregnancy and 
smoking cessation trial conducted in the United King-
dom.32  The frequency of occurrence of adverse events 
and birth outcomes were also similar. These women 
were generally representative of women who smoke,8 
and the findings are likely to be generalisable to pri-
mary and secondary care settings. The prevalence of 
probable depression at baseline is slightly higher than 
that reported for pregnant women in general.33
This study was approximately twice the size of previ-
ous randomised controlled trials investigating physical 
activity interventions for smoking cessation delivered 
through face to face support.12  As anticipated, we 
recruited around 10% of pregnant women recorded as 
smokers at their first antenatal booking visit. However, 
the prevalence of smoking was lower than anticipated; 
therefore, despite extending the recruitment period, 
our sample was only 91% of the target 866. Quit rates 
were lower than anticipated in our power calculation, 
which will also have reduced the power of the study. 
The confidence intervals around the odds ratio for the 
effect of the intervention show the level of precision of 
this estimate, given the achieved sample size, and 
imply that we cannot rule out up to a twofold increase 
in abstinence at the end of pregnancy compared with 
controls at the upper end of the confidence interval, 
although our point estimate suggests an effect of inter-
vention that is unlikely to be clinically meaningful. 
Additionally, at our four week outcome, quit rates were 
table 2 | Compliance to interventions
assessment time Physical activity group Control group relative change* (95% Ci) P value
no, median (interquartile range) self reported weekly MvPa (mins)
Baseline 391, 210 (125-350) 393, 225 (130-360) — —
No of weeks post-quit day:
 1 162, 280 (190-425) 206, 240 (140-420) 1.33 (1.14 to 1.56) <0.001
 4 135, 270 (180-420) 157, 210 (120-340) 1.28 (1.07 to 1.52) 0.006
 6 90, 277 (180-400) 121, 220 (130-350) 1.36 (1.12 to 1.65) 0.002
End of pregnancy 188, 155 (100-240) 187, 140 (60-240) 1.25 (0.96 to 1.61) 0.093
6 month follow-up 147, 180 (80-330) 136, 135 (60-285) 1.16 (0.85 to 1.59) 0.339
no, mean (sD) time walked on treadmill during supervised exercise (mins)
Baseline 390, 12.2 (7.5) — — —
No of weeks post-quit day:
 1 163, 19.0 (8.5) — — —
 4 134, 15.2 (10.8) — — —
 6 90, 17.7 (10.9) — — —
No of treatment sessions attended 391, 4 (2-8)† 393, 3 (2-6)
MVPA=moderate-vigorous physical activity.
*Relative change of physical activity mixed effect model for log of physical activity. Adjusted for visit time, baseline minutes of MVPA, interaction of visit 
time and baseline minutes of MVPA, and recruitment centre.
†Median (interquartile range) numbers of sessions attended for both physical activity counselling and smoking cessation behavioural support were 2 
(1-4). Participants received supervised exercise at all sessions.
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higher and confidence intervals narrower, and the dif-
ference in abstinence between treatment and control 
was minimal even at the upper end of the confidence 
interval. Thus despite not reaching the target sample 
size, our results suggest there is unlikely to be a clini-
cally relevant difference. Quit rates were lower than in 
previous pregnancy trials with less rigorous outcome 
measures but were similar to those for studies using 
comparable outcome measures.8  For example, two pre-
vious UK based large trials of a smoking cessation inter-
vention during pregnancy observed quit rates at the 
end of pregnancy of 7.6% and 7.8% in a group only 
receiving behavioural support for smoking32  34; simi-
larly, we observed a quit rate of 6.4% for this group.
interpretation of findings
Bias in outcome ascertainment is unlikely to explain the 
findings, as follow-up rates (at 89%) were equally high 
in the groups, and for only 6% of participants who 
could not be followed-up was it necessary to assume 
that they had continued to smoke or relapse. Also, the 
effect size was independent of the influence of missing 
outcome data. Less than 10% reported using non-study 
behavioural support or nicotine replacement therapy, 
with similar usage in the groups; therefore it is doubtful 
that this influenced the results. Low attendance may 
have affected the outcomes; women in the physical 
activity group attended a median of only four of 14 ses-
sions. However, despite low attendance rates, the coun-
selling on physical activity may still have substantially 
increased physical activity levels. Low attendance was 
not explained by the two potentially treatment related 
adverse events in the physical activity group, and there 
was no indication that the physical activity intervention 
increased the incidence of adverse events. As is com-
mon in smoking cessation trials, the majority of women 
who failed to quit stopped attending, suggesting that it 
was failure of quitting that partly led to low attendance. 
Qualitative data (to be reported elsewhere) based on 
interviews with participants suggests that low atten-
dance was also influenced by pregnancy related ail-
ments, poor psychological health, and lack of social 
support.
Evidence for the intervention influencing processes 
that might aid cessation, such as confidence for quit-
ting, urges to smoke, or withdrawal symptoms was 
lacking. There was also no evidence for the intervention 
reducing depression scores; moreover, scores were sig-
nificantly higher in the physical activity group than 
control group at the end of pregnancy; although the 
margin of this difference was small and unlikely to be 
clinically important.35  36 A possible explanation for the 
depression findings, which is consistent with our qual-
itative data (to be reported elsewhere), relates to the 
population of interest and the requirements of the inter-
vention. Those in the intervention group were asked to 
change two health behaviours simultaneously (that is, 
smoking and physical activity), while also coping with 
being pregnant and attending multiple treatment ses-
sions. Participants might have been demoralised by 
finding this difficult to achieve, resulting in marginally 
higher depression scores at the end of pregnancy. Nei-
ther was there evidence that the intervention reduced 
weight gain. The effects on outcomes for smoking cessa-
tion, depression, and weight may have been limited by 
having an intervention group with an already active 
lifestyle and that failed to sufficiently raise their physi-
cal activity levels, compared with the control group.
It is reassuring that the numbers of adverse events 
were similar in the two groups, as it suggests that a 
physical activity intervention is safe and is unlikely to 
increase these events in pregnant smokers. Moreover, 
there were 7% fewer caesarean sections in the physical 
activity compared with control group. This finding is 
consistent with a recent meta-analysis that observed a 
significantly lower risk of caesarean delivery among 
women undergoing a physical activity intervention 
table 3 | Primary and secondary abstinence outcomes. values are numbers (percentages) unless stated otherwise
Outcomes
Physical activity group 
(n=392)
Control group  
(n=393)
Odds ratio* (95% Ci) 
with basic adjustment
Fully adjusted odds 
ratio† (95% Ci)
Primary:
  Self reported continuous abstinence‡ at end of pregnancy§ 
with biochemical validation¶
30 (8) 25 (6) 1.21 (0.70 to 2.10) 1.37 (0.78 to 2.41)
Secondary:
  Self reported continuous abstinence 4 weeks post-quit day, 
with validation**
50 (13) 61 (16) 0.79 (0.53 to 1.18) 0.87 (0.57 to 1.31)
 Self reported continuous abstinence 6 months after birth 24 (6) 16 (4) 1.55 (0.81 to 2.97) 1.66 (0.82 to 3.37)
*Adjusted for recruitment centre only (as a stratification factor).
†Adjusted for recruitment centre, Fagerstrom test of cigarette dependence score at baseline, participant’s age at randomisation, Edinburgh postnatal depression scale score at baseline, age at 
leaving full time education, and partner’s smoking status at baseline. 
‡Smoked fewer than five cigarettes since quit day.
§Between 36 weeks’ gestation and 10 weeks after birth.
¶Validated by exhaled carbon monoxide or salivary cotinine levels, or both; if both measures were available both were required for validation. Biochemical tests did not validate report of not 
smoking (that is, probable false reporting of cessation) in 12 of 42 women (29%) in physical activity group and 19 of 44 (43%) in control group.
**Biochemical tests did not validate report of not smoking (that is, probable false reporting of cessation) in 4 of 51 women (8%) in physical activity group and in 7 of 61 (11%) in control group.
table 4 | Maternal depression. values are numbers, means (standard deviations) unless 
stated otherwise
visit time
ePDs score β (difference between physical 
activity and control group) (95% Ci)*Control group Physical activity group
Baseline 393, 7.7 (5.0) 391, 7.6 (5.3) 0
End of pregnancy 194, 7.2 (5.0) 189, 8.0 (4.9) 1.06 (0.19 to 1.94)
6 month follow-up 133, 6.6 (4.7) 146, 6.8 (4.8) 0.52 (−0.45 to 1.50)
EPDS=Edinburgh postnatal depression scale.
*Results from mixed effect linear regression model, adjusted for visit time, baseline EPDS score, interaction of 
visit time and baseline EPDS score, and recruitment centre.
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compared with control conditions.37 This is the first 
study to report this in pregnant smokers and it is a pos-
itive result as caesarean sections are more expensive to 
the NHS than other modes of delivery and there are 
complications associated with abdominal surgery.
According to self reports, we recruited physically 
active women who were at baseline, compared with 
pregnant smokers similarly recruited in antenatal hos-
pitals,38 twice as likely to report achieving the recom-
mended levels of physical activity; this may be because 
active women were attracted to a trial promoting physi-
cal activity. It is likely that similarly active women 
would be recruited to a physical activity intervention 
delivered in routine healthcare. A further explanation is 
that a high proportion of participants were living in 
deprived communities, and our qualitative data (to be 
reported elsewhere) suggests that the women had lim-
ited access to motorised or public transport, relying on 
walking as their main form of transport. This could 
mean that most participants were already experiencing 
the benefits of exercise, making it difficult to detect an 
appreciable difference in smoking abstinence rates 
between the trial groups (that is, a ceiling effect). There 
was no evidence to suggest that the treatment effect was 
influenced by baseline levels of physical activity; 
although there was insufficient power to detect this 
interaction and it is possible that the intervention 
would have shown stronger effects if a more sedentary 
population had been targeted.
An alternative explanation is that participants 
over-reported their activity levels. This is supported by 
the accelerometer data, which shows, as previously 
observed,39 that physical activity levels were far higher 
by self report than by accelerometer. A limitation is that 
only 90 participants were monitored by accelerometer. 
The baseline characteristics of these women were simi-
lar to the remainder who did not wear accelerometers. It 
would have been preferable to assess physical activity 
using the accelerometer in all participants, but our pilot 
study showed that most women would not tolerate 
wearing them and so we used self reported activity for 
the primary analysis.
Participants could not be blinded to treatment allo-
cation, and the higher self reports of activity in the 
physical activity group compared with the control 
group may be biased by knowledge of allocation. This 
is consistent with the finding that the overestimate of 
self reported physical activity, versus the accelerometer 
data, tended to be higher for the physical activity ver-
sus control group. Additionally, accelerometer derived 
physical activity levels were similar in the two trial 
groups, although when including all moderate-vigor-
ous physical activity (rather than restricting it to bouts 
of ≥10 minutes) the physical activity group tended to 
report more physical activity a week than the control 
group, which suggests that most increases in activity 
were likely to be in sporadic bouts lasting less than 10 
minutes. Thus it remains possible that women in the 
physical activity group failed to increase their physical 
table 5 | Maternal body weight. values are means (standard deviations) unless stated 
otherwise
subsamples of maternal body 
weight
Physical activity 
group Control group
Mean difference 
(physical activity−
control) (95% Ci)*
Gestational weight change†: n=74 n=66
 Early pregnancy weight 68.3 (14.4) 70.3 (15.6) —
 End of pregnancy weight 80.7 (14.9) 81.4 (14.8) 1.08 (−1.08 to 3.23)
Postnatal weight retention‡: n=63 n=65
 Early pregnancy weight 66.1 (14.6) 66.2 (12.8) —
 End of pregnancy weight 70.7 (14.1) 71.3 (13.4) −0.11 (−2.27 to 2.49)
*Linear regression model with maternal weight change at end of pregnancy as dependent variable, and 
randomisation groups, early pregnancy weight, and recruitment centre as independent variables.
†Weight measured before birth.
‡Weight measured after birth.
table 6 | birth outcomes by treatment group. values are number with outcome/total number in group (percentage) unless stated otherwise
Fetal outcomes (singleton births only*) Physical activity group (n=384) Control group (n=391) Odds ratio† (95% Ci)
Miscarriage‡ 6/383 (2) 10/389 (3) 0.60 (0.22 to 1.67)
Stillbirth‡ 2/377 (1) 2/379 (1) 1.01 (0.14 to 7.24)
Neonatal death‡ 0 1/391 (0.3) Not calculated
Mean (SD) birth weight (g) n=354, 3132.4 (581.7) n=359, 3146.8 (640.0) −14.50 (−104.52 to 75.52)
Mean (SD) gestational age at delivery (weeks) n=356, 39.24 (2.1) n=348, 39.26 (2.1) −0.02 (−0.36 to 0.31)
Preterm birth§ (<37 weeks’ gestation) 35/356 (10) 26/348 (7) 1.36 (0.80 to 2.31)
Low birth weight§ (<2500 g) 38/353 (11) 44/359 (12) 0.87 (0.55 to 1.38)
Admission to neonatal intensive care unit 27/352 (8) 36/356 (10) 0.74 (0.44 to 1.25)
Apgar score at 5 minutes <7 8/344 (2) 11/351 (3) 0.74 (0.29 to 1.85)
Cord blood arterial pH <7 2/130 (2) 0/125 Not calculated
Congenital abnormalities¶ 9/346 (3) 6/348 (2) 1.43 (0.50 to 4.13)
Assisted vaginal delivery 46/357 (13) 32/359 (9) 1.51 (0.94 to 2.43)
Caesarean delivery 76/357 (21) 103/359 (29) 0.67 (0.48 to 0.95)**
*For all outcomes, 10 women with twins (8 in physical activity group) were removed from the denominator. When including twin births the findings for birth outcomes were similar. 
†Odds ratios and mean differences were adjusted for recruitment centre (as a stratification factor).
‡These outcomes were defined a priori as serious adverse events. They were not specified as outcomes in the published protocol and therefore are considered as post hoc outcomes. There 
were no maternal deaths, and no serious adverse events were judged to be related to the physical activity intervention. The denominator for miscarriage was calculated as the number 
randomised minus the number of elective terminations (n=3) (elective terminations are excluded as they do not have the potential to miscarry). The denominator for stillbirth was calculated as 
the number randomised minus the number of miscarriages and elective terminations (elective terminations and miscarriages were excluded as they do not have the potential to result in a 
stillbirth). For all other outcomes, the denominator is the number of singleton live births, excluding those births for which outcome data were missing.
§These variables were not specified as outcomes in the protocol and therefore are considered as post hoc outcomes.
¶See supplementary table on bmj.com for a list of congenital abnormalities.
**P=0.023.
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activity levels compared with the control group, as 
planned. If this was the case, it is unlikely that such an 
intervention offered in routine healthcare would raise 
physical activity levels sufficiently to aid smoking ces-
sation. A less pragmatic and more efficacy oriented 
trial (for example, with greater incentives, such as 
financial, to complete the exercise), and with acceler-
ometer measurement in the whole sample, would be 
needed to establish whether physical activity in itself 
aids smoking cessation during pregnancy. There was 
no evidence that change in self reported physical activ-
ity was associated with higher quit rates, although this 
analysis was underpowered and the confidence inter-
vals were wide.
Conclusions
In this study, evidence that a pragmatic physical activ-
ity intervention was effective for aiding smoking cessa-
tion was lacking. An efficacy trial involving thrice 
weekly sessions of vigorous intensity supervised exer-
cise observed a benefit of a physical activity interven-
tion on long term smoking abstinence among 
non-pregnant women smokers11; therefore it remains 
possible that a more intensive intervention may aid 
smoking cessation during pregnancy. However, more 
intensive exercise may be clinically inappropriate in 
pregnancy, and experience from the trial suggests that 
uptake of an intensive intervention would be low and 
would be difficult to integrate into routine healthcare. 
In addition, the provision of a comprehensive pro-
gramme of supervised exercise represents a large 
investment and, to justify such a programme, the effect 
of the intervention would need to be substantial. We 
conclude that the reported physical activity programme 
is unlikely to assist pregnant smokers in stopping 
smoking. However, recommending physical activity to 
pregnant women clearly remains indicated for general 
health during pregnancy.
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